{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:10:27Z","timestamp":1793038227140,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s42358-018-0003-2","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T14:01:37Z","timestamp":1531317697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human immunodeficiency virus in a cohort of systemic lupus erythematosus patients"],"prefix":"10.1186","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3240-7174","authenticated-orcid":false,"given":"Vanessa","family":"Hax","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Laura Didonet","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaella Romeiro","family":"Piovesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano Zubaran","family":"Goldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Machado","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odirlei Andre","family":"Monticielo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"2","key":"3_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.semarthrit.2014.05.009","volume":"44","author":"GM Mody","year":"2014","unstructured":"Mody GM, Patel N, Budhoo A, Dubula T. Concomitant systemic lupus erythematosus and HIV: case series and literature review. Semin Arthritis Rheum. 2014;44(2):186\u201394.","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"3_CR2","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61(6):554\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.berh.2005.03.010","volume":"19","author":"B Griffiths","year":"2005","unstructured":"Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005;19(5):685\u2013708.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"3_CR6","first-page":"67","volume":"44","author":"I Sekigawa","year":"2002","unstructured":"Sekigawa I, Okada M, Ogasawara H, et al. Lessons from similarities between SLE and HIV infection. J Inf Secur. 2002;44(2):67\u201372.","journal-title":"J Inf Secur"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02771754","volume":"14","author":"BR Kaye","year":"1996","unstructured":"Kaye BR. Rheumatologic manifestations of HIV infections. Clin Rev Allergy Immunol. 1996;14:385\u2013416.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/aid.1990.6.481","volume":"6","author":"WP Tsai","year":"1990","unstructured":"Tsai WP, Nara PL, Kung HF, Oroszlan S. Inhibition of immunodeficiency virus infectivity by chloroquin. AIDS Res Hum Retrovir. 1990;6:481\u20139.","journal-title":"AIDS Res Hum Retrovir"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1191\/096120300678828136","volume":"9","author":"I Sekigawa","year":"2000","unstructured":"Sekigawa I, Lee S, Kaneko H, et al. The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus. Lupus. 2000;9:155\u20136.","journal-title":"Lupus"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0889-857X(21)00096-X","volume":"17","author":"RA Furie","year":"1991","unstructured":"Furie RA. Effects of human immunodeficiency virus infection on the expression of rheumatic illness. Rheum Dis Clin North Am. 1991;17:177\u201388.","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"3_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","volume":"1","author":"G Zandman-Goddard","year":"2002","unstructured":"Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002;1(6):329\u201337.","journal-title":"Autoimmun Rev"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0002-9343(88)90012-5","volume":"84","author":"RG Kopelman","year":"1988","unstructured":"Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med. 1988;84:82\u20138.","journal-title":"Am J Med"},{"key":"3_CR13","first-page":"1880","volume":"20","author":"F Medina-Rodriguez","year":"1993","unstructured":"Medina-Rodriguez F, Guzman C, Jara LJ, et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol. 1993;20:1880\u20134.","journal-title":"J Rheumatol"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/jaut.1999.0324","volume":"13","author":"C Petrovas","year":"1999","unstructured":"Petrovas C, Vlachouyiannopoulos PG, Kordossis T, Moutsopoulos M. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with B2-GPI. J Autoimmun. 1999;13:347\u201355.","journal-title":"J Autoimmun"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1097\/00002030-199715000-00009","volume":"11","author":"PS Massabki","year":"1997","unstructured":"Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LEC. Clinical implications of autoantibodies in HIV infection. AIDS. 1997;11:1845\u201350.","journal-title":"AIDS"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/archinte.1989.00390080091020","volume":"149","author":"MM Stimmler","year":"1989","unstructured":"Stimmler MM, Quismorio FP Jr, McGehee WG, Boylen T, Sharma OP. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med. 1989;149:1833\u20135.","journal-title":"Arch Intern Med"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/00002030-199209000-00004","volume":"6","author":"S Muller","year":"1992","unstructured":"Muller S, Richalet P, Laurent-Crawford A, et al. Autoantibodies typical of non-organ-specific autoimmune disease in HIV-seropositive patients. AIDS. 1992;6:933\u201342.","journal-title":"AIDS"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1097\/00002030-199306000-00021","volume":"7","author":"A Lafeuillade","year":"1993","unstructured":"Lafeuillade A, Ritter J, Pellegrino P, Qiulichini R, Monier JC. Lack of anti-nuclear antibodies during HIV infection (correspondence). AIDS. 1993;7:893.","journal-title":"AIDS"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/sarh.2001.23149","volume":"30","author":"BE Daikh","year":"2001","unstructured":"Daikh BE, Holyst MM. Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review. Semin Arthritis Rheum. 2001;30:18\u201325.","journal-title":"Semin Arthritis Rheum"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.semarthrit.2009.12.001","volume":"40","author":"S Gindea","year":"2010","unstructured":"Gindea S, Schwartzman J, Herlitz LC, et al. Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge. Semin Arthritis Rheum. 2010;40:201\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"3_CR21","first-page":"347","volume":"22","author":"JF Molina","year":"1995","unstructured":"Molina JF, Citera G, Rosler D, et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol. 1995;22:347\u201350.","journal-title":"J Rheumatol"},{"key":"3_CR22","first-page":"1295","volume":"23","author":"VM Byrd","year":"1996","unstructured":"Byrd VM, Sergent JS. Suppression of systemic lupus erythematosus by the human immunodeficiency virus. J Rheumatol. 1996;23:1295\u20136.","journal-title":"J Rheumatol"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/art.1780400623","volume":"40","author":"RA Fox","year":"1997","unstructured":"Fox RA, Isenberg DA. Human immunodeficiency virus infection in systemic lupus erythematosus. Arthritis Rheum. 1997;40:1168\u201372.","journal-title":"Arthritis Rheum"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10067-003-0833-z","volume":"23","author":"T Gould","year":"2004","unstructured":"Gould T, Tikly M. Systemic lupus erythematosus in a patient with human immunodeficiency virus infection \u2013 challenges in diagnosis and management. Clin Rheumatol. 2004;23:166\u20139.","journal-title":"Clin Rheumatol"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1177\/0961203311434106","volume":"21","author":"L L\u00f3pez-L\u00f3pez","year":"2012","unstructured":"L\u00f3pez-L\u00f3pez L, Gonz\u00e1lez A, Vil\u00e1 LM. Long-term membranous glomerulonephritis as the presenting manifestation of systemic lupus erythematosus in a patient with human immunodeficiency virus infection. Lupus. 2012;21:900\u20134.","journal-title":"Lupus"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/096120339600500206","volume":"5","author":"A Gul","year":"1996","unstructured":"Gul A, Inanc M, Yilmaz G, et al. Antibodies reactive with HIV-1 antigens in systemic lupus erythematosus. Lupus. 1996;5:120\u20132.","journal-title":"Lupus"},{"key":"3_CR27","volume-title":"Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation","author":"UNAIDS\/WHO Working Group on Global HIV\/AIDS\/STI Surveillance","year":"2001","unstructured":"UNAIDS\/WHO Working Group on Global HIV\/AIDS\/STI Surveillance 2001 Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation. Available at http:\/\/www.who.int\/hiv\/pub\/epidemiology\/pub4\/en\/ ."},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/aid.1993.9.91","volume":"9","author":"K Sperber","year":"1993","unstructured":"Sperber K, Kalb TH, Stecher VJ, Banerjee R, Mayer L. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retrovir. 1993;9:91\u20138.","journal-title":"AIDS Res Hum Retrovir"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/art.1780390122","volume":"39","author":"K Sperber","year":"1996","unstructured":"Sperber K, Ornstein MH. The anti-inflammatory effect of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis. Arthritis and Rheum. 1996;39:157\u201361.","journal-title":"Arthritis and Rheum"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/01.TP.0000075973.73064.A6","volume":"76","author":"PG Stock","year":"2003","unstructured":"Stock PG, Roland ME, Carlson L, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003;76:370\u20135.","journal-title":"Transplantation"},{"key":"3_CR31","volume-title":"Factsheet","author":"World Health Organization. TB\/HIV Facts","year":"2013","unstructured":"World Health Organization. TB\/HIV Facts. Factsheet. Geneva: World Health Organization; 2013. Available at http:\/\/www.who.int\/tb\/challenges\/hiv\/factsheets\/en"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/08916930500285352","volume":"38","author":"G Zandman-Goddard","year":"2005","unstructured":"Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity. 2005;38:473\u201385.","journal-title":"Autoimmunity"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-018-0003-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-018-0003-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T06:55:41Z","timestamp":1661583341000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-018-0003-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1186\/s42358-018-0003-2","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee of the Hospital de Cl\u00ednicas de Porto Alegre, and an informed consent form was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"12"}}